KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Baxter International (BAX) Research & Development (2016 - 2024)

Baxter International (BAX) has disclosed Research & Development for 16 consecutive years, with $176.0 million as the latest value for Q1 2024.

  • Quarterly Research & Development rose 7.32% to $176.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $530.0 million through Mar 2024, up 13.98% year-over-year, with the annual reading at $518.0 million for FY2025, 12.2% down from the prior year.
  • Research & Development for Q1 2024 was $176.0 million at Baxter International, up from $23.0 million in the prior quarter.
  • The five-year high for Research & Development was $176.0 million in Q1 2024, with the low at $2.0 million in Q4 2022.
  • Average Research & Development over 5 years is $129.2 million, with a median of $139.0 million recorded in 2021.
  • The sharpest move saw Research & Development plummeted 98.52% in 2022, then surged 1050.0% in 2023.
  • Over 5 years, Research & Development stood at $135.0 million in 2020, then changed by 0.0% to $135.0 million in 2021, then tumbled by 98.52% to $2.0 million in 2022, then soared by 1050.0% to $23.0 million in 2023, then soared by 665.22% to $176.0 million in 2024.
  • According to Business Quant data, Research & Development over the past three periods came in at $176.0 million, $23.0 million, and $166.0 million for Q1 2024, Q4 2023, and Q3 2023 respectively.